申请人:Abbott Laboratories
公开号:US05389638A1
公开(公告)日:1995-02-14
The present invention provides a tetrahydroisoquinoline compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof which is an antagonist for alpha-2 adrenoreceptors and/or which inhibits biogenic amine uptake.
本发明提供了一种四氢异喹啉化合物,其化学式为##STR1##或其药用可接受的盐,该化合物是α-2肾上腺素受体的拮抗剂和/或抑制生物胺摄取的。